Complementary nature of electrocardiographic and magnetocardiographic data in patients with ischemic heart disease
Abstract
High resolution body surface potential maps (BSPM) and magnetic field maps (MFM) for study groups consisting of 11 Q wave and 11 non Q wave myocardial infarct (MI) patients as well as 9 normal subjects, were recorded in a magnetically and electrically shielded room. A control group of 22 normal subjects provided group mean normal time integral maps for selected QRST time intervals. The difference between magnitudes of extrema in each map defined the normal mean data range R for that time interval. The root mean square sum of the differences between the time integral map of a study subject and the normal group-mean map provided an estimate of individual map variability, V. Subsequent calculation of group-mean map variability, V, and group-mean normalized variability, V/R, for specific time intervals of the cardiac cycle, were used to test the abilities of BSPM and MFM techniques to distinguish between the normal and MI study groups. Results indicate that BSPM V/R differences between MI and normal groups are most pronounced during Q wave and Q zone activity; between inferior MI's and normals (p less than 0.05) and between anterior MI's and normal (p less than 0.01). Significant differences in MFM V/R occur during repolarization; between inferior MI's and non Q wave MI's (p less than 0.05), between anterior MI's and normals (p less than 0.05), between non Q wave MI's and normals (p less than 0.05) and between all MI's and normals (p less than 0.01). It is concluded that high…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 22 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.